Skip to main content
. 2021 Oct 22;17(15):4340–4352. doi: 10.7150/ijbs.64675

Figure 2.

Figure 2

CEP suppresses Hep3B and HCCLM3 cell proliferation. (A, C) Cell cycle of Hep3B and HCCLM3 cells treated with CEP at 5 μM, 10 μM and 20 μM for 48h were analyzed by flow cytometry. (B, D) Percentage of indicated Hep3B and HCCLM3 cells in different phase. (E) Clone formation of Hep3B and HCCLM3 cells treated with CEP at 5 μM, 10 μM and 20 μM. (F, G) Quantification of the clone formation of Hep3B and HCCLM3 cells in (E) was performed by calculating the cell counts. Data shown are means ± SD; n=3. *P< 0.05, significantly from control group.